During the past decade, Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Wielkopolskie Centrum Pulmonologii i Torakochirurgii" with 2 trials sponsored, "Eisai Inc." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Loxo Oncology, Inc." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu" are "Non-Small Cell Lung Cancer" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Small Cell Lung Cancer" (2 trials), "COPD" (1 trials) and "Complication of Surgical Procedure" (1 trials). Many other conditions were trialed in "Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu" in a lesser frequency.

Most popular intervention types in "Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu" are "Drug" (15 trials), "Biological" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (7 trials), "Atezolizumab" (5 trials), "Pemetrexed" (5 trials), "Cisplatin" (4 trials) and "Gemcitabine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Wielkopolskie Centrum Pulmonologii i Torakochirurgii w Poznaniu has several departments that took part in Clinical trials: "Oddzial Onkologii Klinicznej z Pododdzialem Dziennej Chemioterapii" - 3 trials